Stocks
Intellia Therapeutics (NTLA) Net margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -215.1% | -216.5% | -785.8% | -940.5% | -1 327% | -1 113% | ||
| Changes by years, y/y, % | +65pp | -1pp | -569pp | -155pp | -386pp | +36.5% | |||
Intellia Therapeutics. Net margin, %
Intellia Therapeutics. Net margin, changes, pp
Intellia Therapeutics (NTLA) Net margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Net margin, % | ? | -1 019% | -6 894% | -371.3% | -2 113% | -1 490% | -1 113% | |
| Changes by years, y/y, % | -180pp | -6 034pp | +361pp | -1 203pp | -470pp | |||
| Changes by quarters, q/q, % | -109pp | -5 875pp | +6 523pp | -1 741pp | +623pp | |||
